Cargando…
PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
BACKGROUND: Docetaxel (DOC) is widely used as a chemotherapy drug for various tumors, including gastric cancer (GC), but the clinical application of DOC has been limited due to the hydrophobicity of the drug. We aimed to formulate a multifunctional nanoparticle (NP) system to reduce the side effects...
Autores principales: | Xu, Shijie, Cui, Fangbo, Huang, Dafu, Zhang, Dinghu, Zhu, Anqing, Sun, Xia, Cao, Yiming, Ding, Sheng, Wang, Yao, Gao, Eryun, Zhang, Fenglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302817/ https://www.ncbi.nlm.nih.gov/pubmed/30587982 http://dx.doi.org/10.2147/IJN.S175340 |
Ejemplares similares
-
BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
por: Wang, Kan, et al.
Publicado: (2011) -
Efficacy and Specificity of a Monoclonal Antibody‐Drug Conjugate in Chemotherapy by Intratumoral Injection
por: Kitamura, Kazuya, et al.
Publicado: (1992) -
Studies on polyethylene glycol-monoclonal antibody conjugates for fabrication of nanoparticles for biomedical applications
por: Fisusi, Funmilola, et al.
Publicado: (2020) -
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023) -
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)